Surgical Outcome After Treatment of Radiation-Induced Scleral Necrosis in Patients With Uveal Melanoma.
Journal
Cornea
ISSN: 1536-4798
Titre abrégé: Cornea
Pays: United States
ID NLM: 8216186
Informations de publication
Date de publication:
09 Feb 2024
09 Feb 2024
Historique:
received:
07
09
2023
accepted:
03
12
2023
medline:
9
2
2024
pubmed:
9
2
2024
entrez:
9
2
2024
Statut:
aheadofprint
Résumé
Surgical repair might be required in patients with uveal melanoma (UM) that develop advanced forms of radiation-induced scleral necrosis (RISN). In this monocentric long-term observational study, we aimed at analyzing the treatment outcome after RISN surgery. All consecutive cases with UM who underwent surgical intervention for RISN between 1999 and 2020 were included. Achievement of the tectonic stability and evaluation of incidence and the risk factors for a repetitive patch surgery (RPS) were the main endpoints. The final analysis included 57 patients (mean age: 58.7 years; 63.2% female patients), where 55 individuals underwent a patch grafting, and 2 cases were treated with conjunctival reconstructive surgery. The mean follow-up time after grafting was 38.5 months (0.03-221.1 months). Tectonic stability was achieved in 56 (98.3%) patients. Scleral graft (38/55, 69.1%) was the most frequent patching material, followed by Tutopatch (7/55, 12.7%), corneal graft (7/55, 12.7%), dura graft (2/55, 3.6%), and fascia lata (FL) graft (1/55, 1.8%). Eleven patients (20%) underwent RPS after the mean time of 12.9 months (0.3-50.3 months). In the final multivariate Cox regression analysis, the use of Tutopatch (5/7; 71.4%, adjusted hazard ratio = 4.66, P = 0.044) and RISN progression after patch grafting (9/11; 81.8%, adjusted hazard ratio = 9.67, P = 0.008) were independent risk factors for RPS. RISN surgery maintains long-term tectonic stability in most of the cases underwent surgical repair for RISN after brachytherapy for UM. Depending on graft material and, particularly, further RISN progression, an RPS might be necessary in certain cases.
Identifiants
pubmed: 38334485
doi: 10.1097/ICO.0000000000003483
pii: 00003226-990000000-00480
doi:
Types de publication
Journal Article
Langues
eng
Sous-ensembles de citation
IM
Informations de copyright
Copyright © 2024 Wolters Kluwer Health, Inc. All rights reserved.
Déclaration de conflit d'intérêts
The authors have no funding or conflicts of interest to disclose.
Références
Ruiz-Lozano RE, Garza-Garza LA, Davila-Cavazos O, et al. The clinical and pathogenic spectrum of surgically-induced scleral necrosis: a review. Surv Ophthalmol. 2021;66:594–611.
Doshi RR, Harocopos GJ, Schwab IR, et al. The spectrum of postoperative scleral necrosis. Surv Ophthalmol. 2013;58:620–633.
Kaliki S, Shields CL, Rojanaporn D, et al. Scleral necrosis after plaque radiotherapy of uveal melanoma: a case-control study. Ophthalmology. 2013;120:1004–1011.
Jabbarli L, Guberina M, Biewald E, et al. Scleral necrosis after brachytherapy for uveal melanoma: analysis of risk factors. Clin Exp Ophthalmol. 2021;49:357–367.
Chaudhry IA, Liu M, Shamsi FA, et al. Corneoscleral necrosis after episcleral Au-198 brachytherapy of uveal melanoma. Retina. 2009;29:73–79.
Kobtan H. Use of autologous fascia lata as a natural biomaterial for tectonic support in surgically induced necrotizing scleritis. Eye. 2015;29:580–584.
Thatte S, Gupta L. Amniotic membrane transplantation in surgically induced necrotizing scleritis with peripheral ulcerative keratitis. Middle East Afr J Ophthalmol. 2012;19:419–421.
Cho CH, Lee SB. Biodegradable collagen matrix (Ologen) implant and conjunctival autograft for scleral necrosis after pterygium excision: two case reports. BMC Ophthalmol. 2015;15:140.
Barman M, Finger PT, Milman T. Scleral patch grafts in the management of uveal and ocular surface tumors. Ophthalmology. 2012;119:2631–2636.
Zahiti-Rashiti K, Meyer P, Goldblum D. Oral mucosa as a treatment option in perforating scleral necrosis after proton beam radiation therapy. Klin Monbl Augenheilkd. 2018;235:459–460.
Kim JT, Kim KW, Mun SK, et al. Transplantation of autologous perichondrium with amniotic membrane for progressive scleral necrosis. Ocul Surf. 2019;17:571–577.
Spierer O, Waisbourd M, Golan Y, et al. Partial thickness corneal tissue as a patch graft material for prevention of glaucoma drainage device exposure. BMC Ophthalmol. 2016;16:20.
Ram R. Tectonic corneal lamellar grafting for surgically-induced necrotizing scleritis after strabismus surgery: case report & literature review. Am J Ophthalmol Case Rep. 2018;11:28–31.
Singh M, Chew PT, Tan D. Corneal patch graft repair of exposed glaucoma drainage implants. Cornea. 2008;27:1171–1173.
Naseripour M, Aghaei H, Sedaghat A, et al. Corneal patch graft: a new approach for scleral necrosis secondary to plaque radiotherapy. Cornea. 2016;35:565–568.
Scupola A, Blasi MA, Petroni S, et al. Bovine pericardium for scleral closure in transscleral local resection of choroidal melanoma. Retina. 2008;28:1530–1532.
Lind JT, Shute TS, Sheybani A. Patch graft materials for glaucoma tube implants. Curr Opin Ophthalmol. 2017;28:194–198.
Hedergott A, Pink-Theofylaktopoulos U, Neugebauer A, et al. Tendon elongation with bovine pericardium in strabismus surgery-indications beyond Graves' orbitopathy. Graefes Arch Clin Exp Ophthalmol. 2021;259:145–155.
van Hoefen Wijsard M, Haan M, Rietveld E, et al. Donor sclera versus bovine pericardium as patch graft material in glaucoma implant surgery and the impact of a drainage suture. Acta Ophthalmol. 2018;96:692–698.
Smith MF, Doyle JW, Ticrney JW Jr. A comparison of glaucoma drainage implant tube coverage. J Glaucoma. 2002;11:143–147.